AAPL329.89-3.19 (-0.96%) ▼|ABBV262.61+0.84 (+0.32%) ▲|ABT101.85-1.24 (-1.20%) ▼|ACN196.97+1.97 (+1.01%) ▲|ADBE263.14-2.46 (-0.93%) ▼|AMAT418.01-6.21 (-1.46%) ▼|AMD503.78+10.37 (+2.10%) ▲|AMGN378.07-3.43 (-0.90%) ▼|AMT177.02+0.08 (+0.05%) ▲|AMZN248.57-4.97 (-1.96%) ▼|AVGO338.56-6.16 (-1.79%) ▼|AXP324.25-3.53 (-1.08%) ▼|BA210.81+0.54 (+0.25%) ▲|BAC59.53+0.06 (+0.09%) ▲|BKNG171.48-3.87 (-2.21%) ▼|BLK1,054.53-11.07 (-1.04%) ▼|BMY63.77-0.33 (-0.51%) ▼|BNY155.08-2.58 (-1.64%) ▼|BRK-B514.82-0.13 (-0.03%) ▼|C135.48-0.71 (-0.52%) ▼|CAT784.42+0.42 (+0.05%) ▲|CL87.27-0.62 (-0.71%) ▼|CMCSA24.64-0.25 (-0.98%) ▼|COF206.21-0.47 (-0.23%) ▼|COP141.42+4.75 (+3.47%) ▲|COST908.25-10.66 (-1.16%) ▼|CRM259.90+0.47 (+0.18%) ▲|CSCO109.96-0.11 (-0.10%) ▼|CVS94.68-0.87 (-0.91%) ▼|CVX216.90+4.73 (+2.23%) ▲|DE688.12+6.66 (+0.98%) ▲|DHR207.33+4.08 (+2.01%) ▲|DIS107.39-1.20 (-1.11%) ▼|DUK118.11-0.91 (-0.76%) ▼|EMR146.92-1.38 (-0.93%) ▼|FDX309.38-3.19 (-1.02%) ▼|GD357.96+1.15 (+0.32%) ▲|GE309.33-8.23 (-2.59%) ▼|GEV879.12+4.36 (+0.50%) ▲|GILD145.45-0.14 (-0.10%) ▼|GM85.64-1.52 (-1.74%) ▼|GOOG339.69-6.02 (-1.74%) ▼|GOOGL343.19-6.20 (-1.77%) ▼|GS960.68-27.77 (-2.81%) ▼|HD307.53-3.34 (-1.07%) ▼|HON200.72-0.66 (-0.33%) ▼|IBM250.64+1.55 (+0.62%) ▲|INTC97.67+0.48 (+0.49%) ▲|INTU337.51-1.64 (-0.48%) ▼|ISRG376.82-1.12 (-0.30%) ▼|JNJ264.65-1.68 (-0.63%) ▼|JPM345.28-4.85 (-1.39%) ▼|KO88.45-0.38 (-0.42%) ▼|LIN462.65-1.76 (-0.38%) ▼|LLY1,141.46+3.18 (+0.28%) ▲|LMT533.64+4.26 (+0.80%) ▲|LOW195.46-2.71 (-1.37%) ▼|LRCX267.16-6.33 (-2.31%) ▼|MA571.70-2.72 (-0.47%) ▼|MCD254.19-3.30 (-1.28%) ▼|MDLZ62.15-0.25 (-0.39%) ▼|MDT94.03+0.23 (+0.25%) ▲|META666.36+0.76 (+0.11%) ▲|MMM164.31+2.29 (+1.41%) ▲|MO70.13+0.63 (+0.90%) ▲|MRK143.63-0.37 (-0.26%) ▼|MS202.75-3.84 (-1.86%) ▼|MSFT499.41-6.00 (-1.19%) ▼|MU924.85+0.82 (+0.09%) ▲|NEE81.61-0.03 (-0.03%) ▼|NFLX78.33-1.99 (-2.48%) ▼|NKE36.43-0.62 (-1.67%) ▼|NOW145.11+2.76 (+1.94%) ▲|NVDA211.67+0.71 (+0.34%) ▲|ORCL143.08-1.71 (-1.18%) ▼|PEP135.46-0.88 (-0.65%) ▼|PFE27.49-0.24 (-0.85%) ▼|PG147.08+0.95 (+0.65%) ▲|PLTR176.17+2.86 (+1.65%) ▲|PM193.19-1.68 (-0.86%) ▼|QCOM188.57+8.42 (+4.67%) ▲|RTX195.71+0.37 (+0.19%) ▲|SBUX96.62-2.46 (-2.48%) ▼|SCHW108.19+0.88 (+0.82%) ▲|SO86.29-0.71 (-0.82%) ▼|SPG203.98-0.99 (-0.48%) ▼|T26.82+0.31 (+1.17%) ▲|TMO636.22+23.07 (+3.76%) ▲|TMUS181.40-1.50 (-0.82%) ▼|TSLA357.10-1.88 (-0.52%) ▼|TXN263.61+0.19 (+0.07%) ▲|UBER71.93-0.70 (-0.96%) ▼|UNH376.31-7.24 (-1.89%) ▼|UNP284.83-0.25 (-0.09%) ▼|UPS102.58+0.12 (+0.12%) ▲|USB62.28-0.40 (-0.64%) ▼|V374.81-0.47 (-0.13%) ▼|VZ51.57+0.28 (+0.55%) ▲|WFC89.07+0.36 (+0.41%) ▲|WMT108.70-0.38 (-0.35%) ▼|XOM169.31+4.23 (+2.56%) ▲|AAPL329.89-3.19 (-0.96%) ▼|ABBV262.61+0.84 (+0.32%) ▲|ABT101.85-1.24 (-1.20%) ▼|ACN196.97+1.97 (+1.01%) ▲|ADBE263.14-2.46 (-0.93%) ▼|AMAT418.01-6.21 (-1.46%) ▼|AMD503.78+10.37 (+2.10%) ▲|AMGN378.07-3.43 (-0.90%) ▼|AMT177.02+0.08 (+0.05%) ▲|AMZN248.57-4.97 (-1.96%) ▼|AVGO338.56-6.16 (-1.79%) ▼|AXP324.25-3.53 (-1.08%) ▼|BA210.81+0.54 (+0.25%) ▲|BAC59.53+0.06 (+0.09%) ▲|BKNG171.48-3.87 (-2.21%) ▼|BLK1,054.53-11.07 (-1.04%) ▼|BMY63.77-0.33 (-0.51%) ▼|BNY155.08-2.58 (-1.64%) ▼|BRK-B514.82-0.13 (-0.03%) ▼|C135.48-0.71 (-0.52%) ▼|CAT784.42+0.42 (+0.05%) ▲|CL87.27-0.62 (-0.71%) ▼|CMCSA24.64-0.25 (-0.98%) ▼|COF206.21-0.47 (-0.23%) ▼|COP141.42+4.75 (+3.47%) ▲|COST908.25-10.66 (-1.16%) ▼|CRM259.90+0.47 (+0.18%) ▲|CSCO109.96-0.11 (-0.10%) ▼|CVS94.68-0.87 (-0.91%) ▼|CVX216.90+4.73 (+2.23%) ▲|DE688.12+6.66 (+0.98%) ▲|DHR207.33+4.08 (+2.01%) ▲|DIS107.39-1.20 (-1.11%) ▼|DUK118.11-0.91 (-0.76%) ▼|EMR146.92-1.38 (-0.93%) ▼|FDX309.38-3.19 (-1.02%) ▼|GD357.96+1.15 (+0.32%) ▲|GE309.33-8.23 (-2.59%) ▼|GEV879.12+4.36 (+0.50%) ▲|GILD145.45-0.14 (-0.10%) ▼|GM85.64-1.52 (-1.74%) ▼|GOOG339.69-6.02 (-1.74%) ▼|GOOGL343.19-6.20 (-1.77%) ▼|GS960.68-27.77 (-2.81%) ▼|HD307.53-3.34 (-1.07%) ▼|HON200.72-0.66 (-0.33%) ▼|IBM250.64+1.55 (+0.62%) ▲|INTC97.67+0.48 (+0.49%) ▲|INTU337.51-1.64 (-0.48%) ▼|ISRG376.82-1.12 (-0.30%) ▼|JNJ264.65-1.68 (-0.63%) ▼|JPM345.28-4.85 (-1.39%) ▼|KO88.45-0.38 (-0.42%) ▼|LIN462.65-1.76 (-0.38%) ▼|LLY1,141.46+3.18 (+0.28%) ▲|LMT533.64+4.26 (+0.80%) ▲|LOW195.46-2.71 (-1.37%) ▼|LRCX267.16-6.33 (-2.31%) ▼|MA571.70-2.72 (-0.47%) ▼|MCD254.19-3.30 (-1.28%) ▼|MDLZ62.15-0.25 (-0.39%) ▼|MDT94.03+0.23 (+0.25%) ▲|META666.36+0.76 (+0.11%) ▲|MMM164.31+2.29 (+1.41%) ▲|MO70.13+0.63 (+0.90%) ▲|MRK143.63-0.37 (-0.26%) ▼|MS202.75-3.84 (-1.86%) ▼|MSFT499.41-6.00 (-1.19%) ▼|MU924.85+0.82 (+0.09%) ▲|NEE81.61-0.03 (-0.03%) ▼|NFLX78.33-1.99 (-2.48%) ▼|NKE36.43-0.62 (-1.67%) ▼|NOW145.11+2.76 (+1.94%) ▲|NVDA211.67+0.71 (+0.34%) ▲|ORCL143.08-1.71 (-1.18%) ▼|PEP135.46-0.88 (-0.65%) ▼|PFE27.49-0.24 (-0.85%) ▼|PG147.08+0.95 (+0.65%) ▲|PLTR176.17+2.86 (+1.65%) ▲|PM193.19-1.68 (-0.86%) ▼|QCOM188.57+8.42 (+4.67%) ▲|RTX195.71+0.37 (+0.19%) ▲|SBUX96.62-2.46 (-2.48%) ▼|SCHW108.19+0.88 (+0.82%) ▲|SO86.29-0.71 (-0.82%) ▼|SPG203.98-0.99 (-0.48%) ▼|T26.82+0.31 (+1.17%) ▲|TMO636.22+23.07 (+3.76%) ▲|TMUS181.40-1.50 (-0.82%) ▼|TSLA357.10-1.88 (-0.52%) ▼|TXN263.61+0.19 (+0.07%) ▲|UBER71.93-0.70 (-0.96%) ▼|UNH376.31-7.24 (-1.89%) ▼|UNP284.83-0.25 (-0.09%) ▼|UPS102.58+0.12 (+0.12%) ▲|USB62.28-0.40 (-0.64%) ▼|V374.81-0.47 (-0.13%) ▼|VZ51.57+0.28 (+0.55%) ▲|WFC89.07+0.36 (+0.41%) ▲|WMT108.70-0.38 (-0.35%) ▼|XOM169.31+4.23 (+2.56%) ▲|
20.3 C
New York
Tuesday, September 15, 2026

Tag: years

newssourceFORcompanyinformationcontent1releasesmarket

Xinhua Silk Road: China’s TISCO leads green and low-carbon development in steel industry

BEIJING, July 23, 2025 /PRNewswire/ -- In recent years, Taiyuan Iron and Steel (Group) or TISCO, a subsidiary of China Baowu Steel Group Corporation,...

Xinhua Silk Road: China’s TISCO leads green and low-carbon development in steel industry

BEIJING, July 23, 2025 /CNW/ -- In recent years, Taiyuan Iron and Steel (Group) or TISCO, a subsidiary of China Baowu Steel Group Corporation,...

Orla Mining Reports Pit Wall Event at Camino Rojo

VANCOUVER, BC, July 23, 2025 /CNW/ - Orla Mining Ltd. (TSX: OLA; NYSE: ORLA) ("Orla" or the "Company") reports that an uncontrolled material movement...

Palisade Bio Announces Exercise of Previously Issued Warrants for $3.9 Million

Carlsbad, CA, July 23, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical-stage biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced an agreement between the Company and several accredited investors to exercise certain existing warrants (the “Existing Warrants”) to purchase up to an aggregate of 4,318,905 shares of common stock. The Existing Warrants had adjusted exercise prices of $1.40 and were issued by the Company on May 10, 2022; February 1, 2024; May 6, 2024; and December 13, 2024, with each exercise occurring at a reduced exercise price of $0.9047 per share.

Farmers Across Five Provinces: Get Ready for Cleanfarms’ Fall Unwanted Agricultural Pesticides & Obsolete Livestock and Equine Medication Collection

This fall, farmers in five provinces will be able to safely dispose of unwanted agricultural pesticides and obsolete livestock and equine medications.

Children’s Miracle Network Hospitals’ Ignite: Inspiring This Generation to Lift Up the Next Through Impactful Leadership

Annual Peer-to-Peer Leadership Conference Unites Student Leaders and Hospital Advisors to Strengthen Dance Marathon Programs Nationwide ST. LOUIS, July 23, 2025 /PRNewswire/ -- Children's Miracle...

Happy Docs Make Happy Patients

AI technology boosts face-to-face time with patients, earns Mercy national recognition for physician satisfaction ST. LOUIS, July 23, 2025 /PRNewswire/ -- Mercy's strategic and carefully planned...

Subsea7 and Saipem announce signing of the Merger Agreement

NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES, OR IN ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW 

Five Star Bancorp Announces Second Quarter 2025 Results

FDA Clinical Hold on RP-A501 Trial Triggers Rocket Pharmaceuticals (RCKT) Stock Plunge and Class Action – Hagens Berman

SAN FRANCISCO, July 23, 2025 (GLOBE NEWSWIRE) -- When, on May 27, 2025, Rocket Pharmaceuticals (NASDAQ: RCKT) revealed that the FDA put a clinical hold on its Phase 2 pivotal trial for RP-A501, an experimental therapy intended to treat patients with a rare gene disorder called Danon disease, investors in the company’s shares saw their investment crash over 60% that day.

Claudin 18.2-Directed Oncology Therapeutics–A Fast-Growing Market with Blockbuster Potential | DelveInsight

Claudin 18.2-directed therapies are on track to become foundational in the treatment of gastrointestinal and select solid tumors. Fueled by innovation in antibody engineering,...

Claudin 18.2-Directed Oncology Therapeutics–A Fast-Growing Market with Blockbuster Potential | DelveInsight

Claudin 18.2-directed therapies are on track to become foundational in the treatment of gastrointestinal and select solid tumors. Fueled by innovation in antibody engineering,...

Martello and Wesley Clover International Amend Loan Agreement

Amendment extends the loan's maturity date to 2028 at a fixed interest rate of 12%. /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR...

CORE LAB REPORTS SECOND QUARTER 2025 RESULTS

REVENUE OF $130.2 MILLION, UP 5% SEQUENTIALLY AND FLAT YEAR-OVER-YEAROPERATING INCOME OF $15.3 MILLION; EX-ITEMS, $14.5 MILLION, UP OVER 23% SEQUENTIALLY AND DOWN 11%...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsYears

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers